Wagner Wealth Management (South Carolina)’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-200
Closed -$25K 350
2022
Q3
$25K Hold
200
0.02% 280
2022
Q2
$27K Buy
+200
New +$27.3K 0.02% 279
2022
Q1
Sell
-200
Closed -$35K 319
2021
Q4
$35K Buy
+200
New +$30.4K 0.03% 306
2018
Q3
$70K Hold
650
0.05% 227
2018
Q2
$71K Hold
650
0.05% 207
2018
Q1
$65K Sell
650
-400
-38% -$41K 0.05% 199
2017
Q4
$106K Buy
+1,050
New +$99.5K 0.08% 170

Other funds holding DGX

Wagner Wealth Management (South Carolina)'s DGX Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 200 shares — an estimated $25K sold.

Wagner Wealth Management (South Carolina) first reported a position in DGX in Q4 2017 and held it in 7 quarters. The position peaked at $106K in Q4 2017. 880 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 200 Quest Diagnostics shares in Q4 2022, an estimated $25K.
  • Wagner Wealth Management (South Carolina) first reported a position in Quest Diagnostics in Q4 2017 and held it in 7 quarters.
  • Wagner Wealth Management (South Carolina)'s Quest Diagnostics position peaked at $106K in Q4 2017.
  • 880 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.